Michael Geffner
Director Técnico/Científico/I+D en IMMUNOVANT, INC. .
Fortuna: 4 M $ al 31/05/2024
Perfil
Michael Geffner is currently the Chief Medical Officer at Immunovant, Inc. He previously worked as the Senior VP-Development & Medical Affairs at Achillion Pharmaceuticals, Inc. He holds an MBA from Fairleigh Dickinson University and a doctorate from Albany Medical College.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IMMUNOVANT INC
0.10% | 24/04/2024 | 141 616 ( 0.10% ) | 4 M $ | 31/05/2024 |
Cargos activos de Michael Geffner
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMUNOVANT, INC. | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Michael Geffner.
| Empresas | Cargo | Fin |
|---|---|---|
| ACHILLION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 28/01/2020 |
Formación de Michael Geffner.
| Albany Medical College | Doctorate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| IMMUNOVANT, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Geffner
